RELATED ARTICLES |
The approval has been granted to five mg and 10 mg of Zaleplon capsules which are used for insomnia.
With this approval, Orchid has received ANDA approval for 37 drugs. The pharma company has till now filed 58 ANDA filings
Orchid receives US-FDA approval for Zaleplon
Sep 18 2009 , Chennai
City-based Orchid Chemicals & Pharmaceuticals has received the final approval from the US Food
and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Zaleplon Capsules.
The approval has been granted to five mg and 10 mg of Zaleplon capsules which are used for insomnia.
With this approval, Orchid has received ANDA approval for 37 drugs. The pharma company has till now filed 58 ANDA filings
The approval has been granted to five mg and 10 mg of Zaleplon capsules which are used for insomnia.
With this approval, Orchid has received ANDA approval for 37 drugs. The pharma company has till now filed 58 ANDA filings
0 commentsPost your Comment
RELATED VIDEO
Mar 18, 2012
Feb 09, 2012
Feb 07, 2012
Jan 26, 2012
Dec 30, 2011
 Limited.JPG)
Post new comment